Diane J. Bakker

Amsterdam, NH 1105AZ, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Metabolic dependency of malonate protection against cardiac ischemia-reperfusion injury.

Metabolic dependency of malonate protection against cardiac ischemia-reperfusion injury.

Journal: Basic research in cardiology

Published: November 24, 2025

The early metabolic cardiac targets of empagliflozin during the development of heart failure, independent of SGLT2 inhibition.

The early metabolic cardiac targets of empagliflozin during the development of heart failure, independent of SGLT2 inhibition.

Journal: Metabolism: clinical and experimental

Published: September 19, 2025

Sodium-glucose co-transporters (SGLT2) inhibitors prevent lipid droplets formation in vascular inflammation or lipid overload by SGLT2-independent mechanism.

Sodium-glucose co-transporters (SGLT2) inhibitors prevent lipid droplets formation in vascular inflammation or lipid overload by SGLT2-independent mechanism.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 23, 2024

Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2.

Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2.

Journal: Basic research in cardiology

Published: March 05, 2024

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2.

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2.

Journal: Circulation

Published: January 17, 2023

Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol.

Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol.

Journal: Frontiers in cardiovascular medicine

Published: May 20, 2021

The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury.

The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury.

Journal: Cardiovascular drugs and therapy

Published: April 12, 2021

Multiple pathways towards achieving a living income for different types of smallholder tree-crop commodity farmers.

Multiple pathways towards achieving a living income for different types of smallholder tree-crop commodity farmers.

Journal: Food security

Published: March 17, 2021

Empagliflozin Decreases Lactate Generation in an NHE-1 Dependent Fashion and Increases α-Ketoglutarate Synthesis From Palmitate in Type II Diabetic Mouse Hearts.

Empagliflozin Decreases Lactate Generation in an NHE-1 Dependent Fashion and Increases α-Ketoglutarate Synthesis From Palmitate in Type II Diabetic Mouse Hearts.

Journal: Frontiers in cardiovascular medicine

Published: August 06, 2020

NLRX1 Deletion Increases Ischemia-Reperfusion Damage and Activates Glucose Metabolism in Mouse Heart.

NLRX1 Deletion Increases Ischemia-Reperfusion Damage and Activates Glucose Metabolism in Mouse Heart.

Journal: Frontiers in immunology

Published: August 05, 2020

Cardiomyocyte Progenitor Cells as a Functional Gene Delivery Vehicle for Long-Term Biological Pacing.

Cardiomyocyte Progenitor Cells as a Functional Gene Delivery Vehicle for Long-Term Biological Pacing.

Journal: Molecules (Basel, Switzerland)

Published: November 28, 2018

Genetic variation in GNB5 causes bradycardia by augmenting the cholinergic response via increased acetylcholine-activated potassium current (IK,ACh).

Genetic variation in GNB5 causes bradycardia by augmenting the cholinergic response via increased acetylcholine-activated potassium current (IK,ACh).

Journal: Disease models & mechanisms

Published: November 08, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026